US 8431116
Norovirus vaccine formulations
granted A61KA61K2039/5258A61K2039/54
Quick answer
US patent 8431116 (Norovirus vaccine formulations) held by Takeda Vaccines (Montana), Inc. expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Vaccines (Montana), Inc.
- Grant date
- Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2039/5258, A61K2039/54, A61K2039/543, A61K2039/55572